Adeleke S, Haroon A, Kasivisvanathan V. Re: [(177)Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 Trial. Eur Urol 2021 Apr 16. pii: S0302-2838(21)00245.
PMID: 33875309